3D bioprinting

Bio Organs is a biotechnology start-up developing patient-specific, vascularized cardiac tissue patches to help restore heart function after heart attack and delay progress toward heart failure. The patches are made using patient-specific iPSC-derived cardiovascular cells and can connect to the patient's blood supply immediately at implantation while triggering a reduced immune response.

personalized iPSC-derived cell therapiestissue engineering

CELLINK leads the way in 3D bioprinting innovation, developing bioprinters and bioinks for pharma, academic and industry researchers. The company offers award-winning 3D bioprinters and carefully sourced biomaterials and bioinks to enable 3D cell culture research.

2PP printingbiodispensingDLP bioprintingextrusion-based bioprintinglight-based bioprinting

Cytoink engineers GelMA, SilMA, and custom bioinks for DLP, extrusion, and FRESH bioprinting. The company offers 100+ formulations across source, concentration, and additives, with printer-ready, sterile bioinks that ship ambient without a cold chain. Every batch is verified for cell viability, rheology, and printability before shipping, and the company provides support from bioprinting researchers.

batch testing for cell viability, rheology, and printabilitybioink formulationcustom formulationsDLP bioprintingextrusion bioprintingFRESH bioprintingprint parameters optimization

Early Charm is a vertically integrated company that takes science from research institution licenses to commercial production, with R&D and manufacturing under one roof in Baltimore, Maryland. It serves both defense and commercial markets, developing dual-use products across advanced materials, bioengineering and biodefense, and sensors and analytics. The company reports 90 products in its pipeline and 11 fully commercial products, and is an SBIR/STTR awardee that is DCAA-compliant and SAM + CAGE registered.

3d Printingbiomanufacturingcastingcoatingcomputational drug designcustom material formulationdata analyticselectrospinningoptical systemspoint-of-care diagnosticsprecision prototypingsonar-based monitoringspectroscopysurface engineering

EndoGen Constructs is a company founded by two co-founders working on in vivo 3D bioprinting and surgical tools. It is developing an acoustic holography technology to print tissue patches directly inside the human body, and aims to design and fabricate a benchtop ultrasonic 3D bioprinter for testing bioinks. It also works on pediatric surgical devices, aiming to produce simple Class I surgical instruments designed to be 3D printed using previously approved FDA materials, and eventually a digital repository of tool designs for hospitals to 3D print on-pre

3d Printingacoustic holographysurgical tool designultrasonic 3D printing

FluidForm Bio builds living human tissue for better treatment of disease using its patented FRESH 3D bioprinting platform, which builds tissue using cells, proteins, and nothing else. Founded in 2018, the company integrates innovations in 3D printing, computational and synthetic biology, AI and machine learning, and advanced materials science to develop human tissue. Its FRESH 3D bioprinting enables implantable tissue that promotes dense vascularization, with potential application toward a minimally invasive cure for type 1 diabetes.

advanced materials scienceAI and machine learningbiomanufacturingcomputational and synthetic biologyFRESH 3D bioprintingtissue engineering